Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: The therapeutic efficacy of mesenchymal stromal cells on experimental colitis was improved by the IFN-γ and poly(I:C) priming through promoting the expression of indoleamine 2,3-dioxygenase

Fig. 3

The IFN-γ and poly(I:C)-primed MSCs decreased inflammatory response in the spleen, mLN, and colon tissue. Mice with the DSS-induced colitis were sacrificed on day 9 to harvest the spleen, mLN, and colon tissues. Representative data of two independent experiments are presented (normal, n = 3; other groups, n = 4). ac Recovered cells from the spleen and mLN were subjected to the flow cytometric analysis. The infiltration of monocytes (CD11+), dendritic cells (CD11c+), and CD4+ T cells significantly decreased in the primed MSC group compared to the DSS control. d Results of quantitative PCR from colon tissue demonstrated that mRNA expression of inflammatory cytokines (IL-1β, TNF-α, and IL-6) and a chemotactic factor (MCP-1) decreased significantly in the primed MSC group compared to the DSS control. In contrast, the expression of immune-modulating cytokine (IL-10) increased in the same group. e Protein is extracted from the colon tissue, and cytokine concentrations are measured by the ELISA assay (*p < 0.05, **p < 0.01, ***p < 0.001)

Back to article page